Advancements in Germline Gene Editing
Introduction to Gene Editing
Imagine a future free from serious inherited diseases. Recently, scientists in the United States have taken significant steps toward this vision through germline gene editing. A team from Oregon Health & Science University has achieved a groundbreaking milestone by successfully editing human embryonic germline genes.
Details of the Research
While the exact number of edited embryos created prior to success remains unknown, all embryos were destroyed after a few days, making it unclear whether any were viable. The primary aim of this research is to eliminate serious inherited conditions such as Huntington’s Disease and cystic fibrosis before birth.
CRISPR Technology
The findings, reported by the Associated Press, utilized CRISPR, a precise gene-editing technique that allows for the modification or replacement of specific DNA sections. Although other gene therapy methods exist to treat inherited diseases by introducing a healthy DNA copy into non-germline cells, these approaches carry risks of incorrect insertion or unexpected outcomes. In contrast, CRISPR’s modifications to the germline are exact and permanent, ensuring that any changes are inherited by future generations.
Ethical and Legal Considerations
The introduction of this technology has sparked mixed reactions. While some view it as a promising advancement for human health, others express concern, advocating for alternatives such as genetic screening of embryos created via in vitro fertilization (IVF). Germline gene editing raises complex legal and ethical issues, prompting many countries, including the United States, to implement regulatory barriers against its use for reproductive purposes.
Future Possibilities
A report from the National Academies of Sciences and Medicine in February 2017 suggested that germline gene editing might soon be permissible in the U.S. for preventing serious inherited diseases, provided that strict criteria are met. Some researchers in the UK have already received approval for germline gene editing experiments, strictly for research purposes. Nevertheless, concerns remain regarding the enforcement of guidelines and the potential for the technology to be misused in creating “designer” babies.
Conclusion
It is essential to recognize that these recent developments represent only the initial steps in germline gene editing. Future advancements must be approached with caution, as the long-term implications for recipients’ health and safety are still uncertain. Progress in this innovative field may require allowing germline gene editing experiments under stringent regulations. This approach will enable public discourse among ethicists, regulators, and society to evaluate the potential benefits and risks associated with this technique, shaping its future applications.
Sources
Written by Natasha Tetlow, PhD, Marilynn Marchione. In US first, scientists edit genes of human embryos. AP. 2017. Available at: https://apnews.com/d89290fdc63f4eef9d9e32d161179d59 Add to Flipboard Magazine.